This study aims to prospectively compare umbilical venous catheters (UVCs) and peripherally inserted central catheters (PICCs) in neonates, focusing on complications, catheter survival, and central line-associated bloodstream infection (CLABSI) rates
Study Type
OBSERVATIONAL
Enrollment
360
Neonates who received peripherally inserted central catheters within the first 28 days of life.
Neonates who received umbilical venous catheters within the first 28 days of life
catheter survival time
Number of days each catheter remains functional and in use before removal
Time frame: From catheter insertion until removal (up to 28 days of life or until hospital discharge, whichever occurs first)
Central Line-Associated Bloodstream Infection (CLABSI) Incidence
Number of CLABSI events per 1,000 catheter-days, diagnosed according to CDC/NHSN criteria (positive blood culture + clinical signs of sepsis with no other source)
Time frame: During the entire catheterization period (up to 28 days of life or until hospital discharge
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.